Piper Sandler Reiterates Overweight Rating on Sutro Biopharma (STRO)
Go back to Piper Sandler Reiterates Overweight Rating on Sutro Biopharma (STRO)| (NASDAQ: STRO) | Delayed: 21.91 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.91 | 52 Week High | $ | |||
| Open | $21.91 | 52 Week Low | $ | |||
| Day High | $21.91 | P/E | N/A | |||
| Day Low | $21.91 | EPS | $ | |||
| Volume | 3 | |||||

